AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Clinical trials for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD explained in plain language.
Never miss a new study
Get alerted when new AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD trials appear
Sign up with your email to follow new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Robotic surgery may speed recovery for polycystic kidney patients
Disease control OngoingThis study looks at whether using a robot to remove one kidney in people with polycystic kidney disease is safer and leads to a shorter hospital stay than traditional open surgery. Researchers will compare 57 adult patients who had either robotic or open surgery. The goal is to s…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Sponsor: University of Bologna • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Gene study aims to unlock secrets of kidney disease
Knowledge-focused OngoingThis study is for people with autosomal dominant polycystic kidney disease (ADPKD), a condition that causes cysts to grow in the kidneys. Researchers want to learn how different gene variants affect the disease. About 400 participants will provide health information and samples. …
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated May 26, 2026 04:17 UTC
-
AI-Generated patient data could speed up rare kidney disease research
Knowledge-focused OngoingThis study explores whether artificial intelligence can create realistic, privacy-protected health data from real patient records of autosomal dominant polycystic kidney disease (ADPKD). Researchers will use these simulated datasets to run virtual clinical trials and check if the…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC